How distressing is referral to colposcopy in cervical cancer screening?: A prospective quality of life study

Gynecologic Oncology

Volumn 132, Issue 1, 2014, Pages 142-148

  Korfage, Ida J ^a   Essink Bot, Marie Louise ^b   Westenberg, Steven M ^c   Helmerhorst, Theo ^a   Habbema, J Dik F ^a   Van Ballegooijen, Marjolein ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

^c Medical Centre Alkmaar   (Netherlands)

Author keywords

Abnormal Pap; Cervical cancer; CIN; Longitudinal; Quality of life; Screening

Indexed keywords

ADULT; ANXIETY; ARTICLE; CANCER SCREENING; CLINICAL ASSESSMENT; COLPOSCOPY; CONTROLLED STUDY; CUSTODY; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MIDDLE AGED; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; OBSERVATIONAL STUDY; PAPANICOLAOU TEST; PATIENT REFERRAL; PRIORITY JOURNAL; PROSPECTIVE STUDY; PSYCHOLOGICAL CONSEQUENCES QUESTIONNAIRE; QUALITY OF LIFE; SHORT FORM 12; UTERINE CERVIX CANCER;

ABNORMAL PAP; CERVICAL CANCER; CIN; LONGITUDINAL; QUALITY OF LIFE; SCREENING;

ADULT; ANXIETY; COHORT STUDIES; COLPOSCOPY; EARLY DETECTION OF CANCER; FEMALE; HUMANS; LONGITUDINAL STUDIES; MIDDLE AGED; PROSPECTIVE STUDIES; QUALITY OF LIFE; REFERRAL AND CONSULTATION; UTERINE CERVICAL NEOPLASMS;

EID: 84892793409     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2013.11.001     Document Type: Article

References (31)

1. S. Tahseen, and P.C. Reid Psychological distress associated with colposcopy: patients' perception Eur J Obstet Gynecol Reprod Biol 139 2008 90 94
2. A. Valdini, and P. Esielionis Measurement of colposcopy-associated distress using the psychosocial effects of having an abnormal pap smear-questionnaire in a Latina population J Low Genit Tract Dis 8 2004 25 32
3. P. Holowaty, A.B. Miller, T. Rohan, and T. To Natural history of dysplasia of the uterine cervix J Natl Cancer Inst 91 1999 252 258
4. J. Cullen, M.D. Schwartz, W.F. Lawrence, J.V. Selby, and J.S. Mandelblatt Short-term impact of cancer prevention and screening activities on quality of life J Clin Oncol 22 2004 943 952
5. G. Ronco, M. van Ballegooijen, N. Becker, A. Chil, M. Fender, and P. Giubilato et al. Process performance of cervical screening programmes in Europe Eur J Cancer 45 2009 2659 2670
6. M.C. Erasmus Screening Program Cervical Cancer, Report on 2009 [bevolkingsonderzoek baarmoederhalskanker, LEBA rapportage 2009] Available from: http://www.rivm.nl/bevolkingsonderzoeknaarkanker/images/2slagfolder-final.pdf 2011
7. M. Rebolj, M. van Ballegooijen, L.M. Berkers, and D. Habbema Monitoring a national cancer prevention program: successful changes in cervical cancer screening in the Netherlands Int J Cancer 120 2007 806 812
8. L.M. Berkers, M. van Ballegooijen, F.J. van Kemenade, M. Rebolj, M.L. Essink-Bot, and T.J. Helmerhorst et al. [The 1996 revision of the Dutch cervical cancer screening programme: increased coverage, fewer repeat smears and less opportunistic screening] Herziening bevolkingsonderzoek op baarmoederhalskanker 1996: hogere dekkingsgraad, minder herhalingsuitstrijkjes en minder opportunistische screening Ned Tijdschr Geneeskd 402 151 2007 1288 1294
9. R.P. Insinga, A.G. Glass, E.R. Myers, and B.B. Rush Abnormal outcomes following cervical cancer screening: event duration and health utility loss Med Decis Making 27 2007 414 422
10. I. Korfage, M. van Ballegooijen, B. Wauben, C. Looman, J. Habbema, and M.L. Essink-Bot Having a Pap smear, quality of life before and after cervical screening: a questionnaire study BJOG 119 2012 936 944
11. B. Gandek, J.E. Ware, N.K. Aaronson, G. Apolone, J.B. Bjorner, and J.E. Brazier et al. Cross-validation of item selection and scoring for the SF-12 health survey in nine countries: results from the IQOLA project. International quality of life assessment J Clin Epidemiol 51 1998 171 178
12. A.K. van der Bij, S. de Weerd, R.J. Cikot, E.A. Steegers, and J.C. Braspenning Validation of the Dutch short form of the state scale of the Spielberger state-trait anxiety inventory: considerations for usage in screening outcomes Community Genet 6 2003 84 87
13. J. Cockburn, T. De Luise, S. Hurley, and K. Clover Development and validation of the PCQ: a questionnaire to measure the psychological consequences of screening mammography Soc Sci Med 34 1992 1129 1134
14. P. Dolan Modeling valuations for EuroQol health states Med Care 35 1997 1095 1108
15. Central Bureau of Statistics Reported Health and Lifestyle (in Dutch) 2008 Centraal Bureau voor de Statistiek Voorburg/Heerlen, the Netherlands [[updated August 6th, 2008]; Available from: http://statline.cbs.nl/ ]
16. T.M. Marteau, and H. Bekker The development of a six-item short-form of the state scale of the Spielberger state-trait anxiety inventory (STAI) Br J Clin Psychol 31 1992 301 306
17. K. Millar, M. Jelicic, B. Bonke, and A.J. Ashbury Assessment of preoperative anxiety: comparison of measures in patients awaiting surgery for breast cancer Br J Anaesth 74 1995 180 183
18. G. Ong, J. Austoker, and J. Brett Breast screening: adverse psychological consequences one month after placing women on early recall because of a diagnostic uncertainty. A multicentre study J Med Screen 4 1997 158 168
19. A.J. Rijnsburger, M.L. Essink-Bot, E. van As, J. Cockburn, and H.J. de Koning Measuring psychological consequences of screening: adaptation of the psychological consequences questionnaire into Dutch Qual Life Res 15 2006 933 940
20. J.E.J. Ware, K.K. Snow, M. Kosinski, and B.G. Gandek SF-36 Health Survey: Manual and Interpretation Guide 1993 The Health Institute, New England Medical Center Boston, MA
21. B. Efron, and R. Tibshirani An Introduction to the Bootstrap 1993 Chapman & Hall New York
22. R. Development Core Team R: A Language and Environment for Statistical Computing 2008 R Foundation for statistical computing Vienna, Austria
23. G.R. Norman, J.A. Sloan, and K.W. Wyrwich Interpretation of changes in health-related quality of life: the remarkable universality of half a standard deviation Med Care 41 2003 582 592
24. T.C. Wright Jr., M. Schiffman, D. Solomon, J.T. Cox, F. Garcia, and S. Goldie et al. Interim guidance for the use of human papillomavirus DNA testing as an adjunct to cervical cytology for screening Obstet Gynecol 103 2004 304 309
25. C. Wilkinson, J.M. Jones, and J. McBride Anxiety caused by abnormal result of cervical smear test: a controlled trial BMJ 300 1990 440 [Clinical research ed.]
26. L. Hounsgaard, L.K. Petersen, and B.D. Pedersen Facing possible illness detected through screening - experiences of healthy women with pathological cervical smears Eur J Oncol Nurs 11 2007 417 423
27. M.H. Jones, A. Singer, and D. Jenkins The mildly abnormal cervical smear: patient anxiety and choice of management J R Soc Med 89 1996 257 260
28. C. Lerman, S.M. Miller, R. Scarborough, P. Hanjani, S. Nolte, and D. Smith Adverse psychologic consequences of positive cytologic cervical screening Am J Obstet Gynecol 165 1991 658 662
29. M. Drolet, M. Brisson, E. Maunsell, E.L. Franco, F. Coutlee, and A. Ferenczy et al. The psychosocial impact of an abnormal cervical smear result Psychooncology 21 2012 1071 1081
30. N.F. Reelick, W.F. de Haes, and J.H. Schuurman Psychological side-effects of the mass screening on cervical cancer Soc Sci Med 18 1984 1089 1093
31. I.J. Korfage, M. van Ballegooijen, H. Huveneers, and M.L. Essink-Bot Anxiety and borderline PAP smear results Eur J Cancer 46 2010 134 141